Cholecystitis
What's New
Last Posted: Oct 10, 2024
- Immune cell traits and causal relationships with cholecystitis: a mendelian randomization analysis.
Ze-Fa Xiao, et al. Naunyn-Schmiedeberg's archives of pharmacology 2024 0 - Genetic evidence causally linking gastroesophageal reflux disease to cholecystitis: a two-sample mendelian randomization study.
Chao Wang, et al. BMC gastroenterology 2024 0 (1) 301 - Causal association of polyunsaturated fatty acids with biliary tract diseases: A Mendelian randomization study.
Xu Chen, et al. Clinical nutrition ESPEN 2024 0 37-45 - [Genome-wide Mendelian randomization study of the pathogenic role of gut microbiota in benign biliary tract diseases].
J W Zhao, et al. Zhonghua wai ke za zhi [Chinese journal of surgery] 2024 0 (3) 217-223 - Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study.
Kim Min Seo, et al. Obesity (Silver Spring, Md.) 2023 0 - IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Tomioka Yuichiro, et al. Histopathology 2019 0 (3) 365-375 - Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
Singh Nidhi, et al. Free radical research 2019 0 (5) 473-485 - Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
Kawakami Satoshi, et al. BMC cancer 2021 0 (1) 1245 - Asynchronous DNA Replication of Biallelically Expressed Genes in Human Peripheral Blood Lymphocytes as a Prognostic Sign of Cancer.
Tsepenko V V, et al. Sovremennye tekhnologii v meditsine 2021 0 (3) 33-38 - Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma.
Ma Hong-Bing, et al. World journal of gastroenterology 2005 0 (5) 744-7
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: